Spineology raised $7MM in equity of a potential $16MM round. The company has developed Anatomy-Conserving Surgery™ with products that combine miniaturization, articulation and expansion features with tissue dilation and targeted visualization methods for spinal fusion.
In 1Q19, the company marked the milestone of >125 lateral interbody fusion cases successfully completed with the Duo™ Lumbar Interbody Fusion system. Duo is reported to be the first implant to combine PEEK, titanium and graft containment mesh elements, a design intended to minimize nerve and soft tissue disruption and reduce post-op pain and complications associated with the lateral approach to fusion.
In previous funding rounds, Spineology disclosed an annual revenue range of $25MM to $100MM. No revenue was disclosed in this round.
Spineology raised $7MM in equity of a potential $16MM round. The company has developed Anatomy-Conserving Surgery™ with products that combine miniaturization, articulation and expansion features with tissue dilation and targeted visualization methods for spinal fusion.
In 1Q19, the company marked the milestone of >125 lateral interbody...
Spineology raised $7MM in equity of a potential $16MM round. The company has developed Anatomy-Conserving Surgery™ with products that combine miniaturization, articulation and expansion features with tissue dilation and targeted visualization methods for spinal fusion.
In 1Q19, the company marked the milestone of >125 lateral interbody fusion cases successfully completed with the Duo™ Lumbar Interbody Fusion system. Duo is reported to be the first implant to combine PEEK, titanium and graft containment mesh elements, a design intended to minimize nerve and soft tissue disruption and reduce post-op pain and complications associated with the lateral approach to fusion.
In previous funding rounds, Spineology disclosed an annual revenue range of $25MM to $100MM. No revenue was disclosed in this round.
Copy to clipboard 
